The CODE Health Story ~ Founder Dr. Lisa Piper
Overview: CODE Health is an innovative, therapeutic product company dedicated to advancing human health and well-being through cutting-edge biotechnology solutions. We are driven by a mission to harness the power of bioenergetics to develop groundbreaking therapies that address a wide range of health challenges suitable for people and animals.
Mission: Our intention is to transform lives by developing and delivering bioenergetic therapeutic products that optimize the body's energy systems and promote healing at the cellular level. We strive to provide safe, effective, and accessible treatments that contribute to the overall improvement of global health.
Scientific Expertise: At CODE Health, we have assembled a team of world-class scientists, researchers, and clinicians who specialize in bioenergetics, cellular biology, and biotechnology. This multidisciplinary approach allows us to leverage the latest scientific discoveries and technologies to develop our innovative products.
Cutting-Edge Technology: Our state-of-the-art research and development facilities are equipped with quantum technology, enabling us to conduct advanced studies and accelerate the discovery of novel bioenergetic therapies. We stay at the forefront of technological and biochemical advancements to remain pioneers in the industry.
Product Portfolio: CODE Health boasts a diverse portfolio of bioenergetic therapeutic products designed to target various health conditions. Our product categories include:
- Pain Management Therapies: Bioenergetic interventions for pain relief, targeting the root cause of discomfort.
- Cellular Health Enhancers: Specialized formulations that optimize cellular energy production, improving overall cellular function and vitality.
- Immune System Modulators: Bioenergetic products that strengthen the immune system, enhancing the body's ability to defend against infections and diseases.
- Stress Relief Solutions: Innovative treatments to decrease stress and promote relaxation by harmonizing the body's energy flow.
- Anti-aging Formulas: Genetic health formulations are aimed at optimizing cellular metabolism and slow down the aging process, potentially extending a healthy lifespan.
Quality and Safety: CODE Health prioritizes quality and safety in all aspects of our operations. Our products undergo rigorous testing and adhere to strict quality standards to ensure they are safe, effective, and reliable for our customers.
Global Reach: We are committed to making our bioenergetic therapeutic products accessible worldwide. Through strategic partnerships, distribution networks, and collaborations, we aim to expand our reach and impact the lives of millions around the globe.
Ethical and Sustainable Practices: CODE Health is dedicated to conducting business with integrity and promoting sustainable practices. We prioritize ethical considerations in our research, development, and manufacturing processes, ensuring our products have a positive impact on people, animals, and the planet.
Continued Innovation: We remain driven by a passion for innovation and scientific exploration. Our commitment to continuous research and development allows us to evolve and stay at the forefront of bioenergetic therapeutics, continually bringing new and improved solutions to the market.
At CODE Health, we believe that the potential of bioenergetics in therapeutic applications is boundless. We are committed to pushing the boundaries of science and developing transformative products that contribute to a healthier and more vibrant future for humanity.
Meet Our Founders
Dr. Lisa Piper, Ph.D., DNM
Dr. Lisa's educational journey includes a B.S. in Business Management, an M.S. in Health Psychology, and a Board-Certified Doctor of Natural Medicine and Humanitarian Services. Complementing her formal education, she holds certificates in Life Coaching and Quantum Health Coaching, and is a member of The National Society of Leadership and Success. Driven by her passion for understanding consciousness and the energy that drives healing, she's an intuitive energy healer on a mission to transform healthcare with safe, complementary alternatives.
Wendy Cohn-Osborne Owner/Managing Partner
Wendy, armed with 30 years of experience in legal, marketing, and healthcare industries, graduated from The Smith School of Business at the University of Maryland. Wendy's interest in the medical field sparked when she practiced Workers' Compensation and Social Security Disability Law, leading her to co-found a pioneering Medical Funding Company in 2006. In 2019, she became a Managing Partner at PurMed Global, revolutionizing the health and wellness market. An avid animal lover, Wendy finds joy in merging her wellness knowledge with her lifelong passion for animals.
Dr. John McMichael, Ph.D.
Dr. McMichael is our Chief Scientist. He is the President, and founder of the Institute for Therapeutic Discovery. In 2004, he also founded Beech Tree Labs, Inc., a discovery and early-stage development biopharmaceutical company. In 1993, he founded Milkhaus Laboratory, Inc. (MLI), and served as President from MLI’s inception through September 2000. From 1991 to 1992 he was Vice President of Molecular Rx, Inc., a biopharmaceutical company focused on products for managing inflammatory responses. Before this, Dr. McMichael was engaged in independent research and served as general manager of ImmunoTherapeutics, a proprietorship focused on developing new therapeutic products. From 1975 through 1986, Dr. McMichael was Assistant Professor, then Associate Professor, and for the last four years, Professor of Biology and Health Sciences at Edinboro University of Pennsylvania. Dr. McMichael is cited as an inventor on more than 200 domestic and foreign patents. He received his B.S. in Microbiology from the University of Maine and his Ph.D. from Oregon State University in Immunology and Virology, and did his post-doctoral work at the Wistar Institute in Philadelphia, PA.
Located in Providence, RI, Beech Tree Labs, Inc. (BTL) focuses on the discovery and early development of therapeutic agents that address a spectrum of unmet medical needs. The Company has an extensive portfolio of patented formulations for products that treat disorders such as allergies, anxiety, chronic obstructive pulmonary disease, urinary incontinence, benign prostatic hypertrophy, and herpesvirus infections as well as other viral infections.
BTL has conducted 16 successful FDA-authorized phase 2 trials and has out-licensed both technology and products.
A unique aspect of BTL is the revolutionary technology, and the corresponding number of indications it addresses. This level of proven capability is the result of the efforts of its founder and president, John McMichael, Ph.D., the network of veterinarians, practicing physicians, medical scientists, and business relationships he has developed over decades of investigating Resonant Molecular Signaling therapies.